Ivan P. Gergel
2014
In 2014, Ivan P. Gergel earned a total compensation of $4.2M as Senior Vice President and Chief Medical Officer at Nektar Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $227,500 |
|---|---|
| Option Awards | $3,610,890 |
| Salary | $372,728 |
| Other | $2,133 |
| Total | $4,213,251 |
Gergel received $3.6M in option awards, accounting for 86% of the total pay in 2014.
Gergel also received $227.5K in non-equity incentive plan, $372.7K in salary and $2.1K in other compensation.
Rankings
In 2014, Ivan P. Gergel's compensation ranked 1,990th out of 13,032 executives tracked by ExecPay. In other words, Gergel earned more than 84.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,990 out of 13,032 | 85th |
Division Manufacturing | 702 out of 4,966 | 86th |
Major group Chemicals And Allied Products | 218 out of 1,686 | 87th |
Industry group Drugs | 166 out of 1,365 | 88th |
Industry Pharmaceutical Preparations | 138 out of 1,043 | 87th |
Source: SEC filing on April 29, 2016.
Gergel's colleagues
We found four more compensation records of executives who worked with Ivan P. Gergel at Nektar Therapeutics in 2014.